Irene Seipelt und Aeterna Zentaris - Info zur Person

(1 - 22 von 34

)

Aeterna Zentaris Presents Encouraging Preclinical Data on Two Novel...

www.finanznachrichten.de

QUEBEC CITY, Nov PRNewswire/ -- Aeterna Zentaris Inc. , (

Company Database

www.maltesebiotech.com

Aeterna Zentaris Presents Preclinical Data for Its Anti-Cancer PI3K/ Erk by Irene Seipelt, PhD, Director, Preclinical Development at Aeterna Zentaris, at the ...

AEterna Zentaris To Present First In Vitro Data for PI3K Inhibitors...

www.finanznachrichten.de

Irene Seipelt, Eckhard Claus, Tilman Schuster, Emmanuel Polymeropoulos, Michael Teifel, Eckhard Gunther. The abstract reviews, for the first ...

Aeterna Zentaris Presents Encouraging Preclinical Data on ...Medindia

www.medindia.net

— Both posters were presented by Irene Seipelt, Associate Director, Discovery and Preclinical Development at Aeterna Zentaris, during the 22nd ...

Effects of combined administration of rapamycin, tolvaptan ...American Physiological Society Journal

journals.physiology.org

von M Sabbatini · · Zitiert von: 19 — Irene Seipelt (AEterna Zentaris) for the kind gift of a generous amount of AEZ-131 as well as for very valuable assistance. AUTHOR NOTES.

Aeterna Zentaris to Present Phase 2 Results for AEZS ADVFNfr.advfn.com › actualites › Aeterna-Zentaris-to-Prese...

fr.advfn.com

Presenter: Irene Seipelt, Ph.D., Associate Director, Discovery and Preclinical Development, Aeterna Zentaris. Poster session: "Molecular-targeted therapies ...

Aeterna Zentaris Presents Preclinical Data for Its Anti ...PR Newswire

www.prnewswire.com

— Teifel, was presented by Irene Seipelt, PhD, Director, Preclinical Development at Aeterna Zentaris, at the American Association for Cancer ...

Medi Abstracts Cover Page for Philly - ACS Division of ...wizard.musc.edu › mediabstractf2012

wizard.musc.edu

Matthias GerlachIrene Seipelt, Lars Blumenstein, Kai Jung, ... Aeterna Zentaris GmbH, Frankfurt, Hesse , Germany ... AEZS-136 was identified during a medicinal chemistry program to optimize ...

Retail English - Nov 22.indd - ((+)) Health Response

www.healthresponse.ca

QUÉBEC CITY: Aeterna Zentaris Inc. presented posters on encouraging ... by Irene Seipelt, Associate Director, Discovery and Preclinical.

OASIS

www.abstractsonline.com

Irene Seipelt, Lars Blumenstein, Silke Baasner, Gilbert Mueller, Babette Aicher, Michael Teifel, Eckhard Guenther, Matthias Gerlach. Aeterna Zentaris GmbH, Frankfurt am

Current View on the Mechanism of Action of Perifosine in ...Ingenta Connect

www.ingentaconnect.com

von J Fensterle · · Zitiert von: 41 — Joachim Fensterle, Babette Aicher, Irene Seipelt, Michael Teifel* and Juergen Engel. Aeterna ZentarisFrankfurt, Germany.

Aeterna Zentaris - Kommt mit Cetrorelix der Durchbruch?

www.wallstreet-online.de

Seite 1 der Diskussion 'Aeterna Zentaris - Kommt mit Cetrorelix der Durchbruch?' vom im w:o-Forum 'Biotech'.

Dual PI3K/ERK inhibition induces necroptotic cell death of Hodgkin...

www.nature.com

Here we report that the PI3K/ERK dual inhibitor AEZS-136 induced significant ... in a Hct116 mouse model (I. Seipelt, Aeterna Zentaris, personal communication) isotype control (Alexa Fluor 488) (antibodies-online GmbH, Germany, EU) Irene Seipelt, M. G., Lars Blumenstein, Gilbert Mueller, Eckhard ...

Joachim Fensterle
Lars Blumenstein
Juergen Engel

Matthias Gerlach
Gilbert Mueller
Michael Teifel

Person "Seipelt" (3)
Vorname "Irene" (18308)
Name "Seipelt" (197)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Irene Seipelt und Aeterna Zentaris Person-Info

Aeterna Zentaris Presents Encouraging Preclinical Data on Two Novel...

Company Database

AEterna Zentaris To Present First In Vitro Data for PI3K Inhibitors...

Aeterna Zentaris Presents Encouraging Preclinical Data on ...Medindia

Effects of combined administration of rapamycin, tolvaptan ...American Physiological Society Journal

Aeterna Zentaris to Present Phase 2 Results for AEZS ADVFNfr.advfn.com › actualites › Aeterna-Zentaris-to-Prese...

Aeterna Zentaris Presents Preclinical Data for Its Anti ...PR Newswire

patentbuddy: Irene Seipelt

Medi Abstracts Cover Page for Philly - ACS Division of ...wizard.musc.edu › mediabstractf2012

Retail English - Nov 22.indd - ((+)) Health Response

OASIS

Current View on the Mechanism of Action of Perifosine in ...Ingenta Connect

Aeterna Zentaris - Kommt mit Cetrorelix der Durchbruch?

Dual PI3K/ERK inhibition induces necroptotic cell death of Hodgkin...

Aeterna Zentaris Inc. - Seite 3 - Forum - ARIVA.DE

AEterna Zentaris to Present Phase 2 Results for AEZS BioSpace

Current view on the mechanism of action of perifosine in ...National Institutes of Health (.gov)

AEZS News Aeterna Zentaris (AEZS)

Hospital English - Nov 22.indd - ((+)) Health Response

Aeterna Zentaris Announces Results on AEZS-131, a Highly Selective...

Aeterna Zentaris présentera une affiche sur de nouvelles opportunités...

NOVEL PYRIDOPYRAZINE DERIVATIVES, PROCESS OF MANUFACTURING AND USES...

Alle Infos zum Namen "Irene Seipelt"